1. Home
  2. RM vs OCGN Comparison

RM vs OCGN Comparison

Compare RM & OCGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Regional Management Corp.

RM

Regional Management Corp.

HOLD

Current Price

$35.09

Market Cap

390.4M

Sector

Finance

ML Signal

HOLD

Logo Ocugen Inc.

OCGN

Ocugen Inc.

HOLD

Current Price

$1.39

Market Cap

387.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
RM
OCGN
Founded
1987
2013
Country
United States
United States
Employees
N/A
N/A
Industry
Finance: Consumer Services
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
390.4M
387.3M
IPO Year
2012
N/A

Fundamental Metrics

Financial Performance
Metric
RM
OCGN
Price
$35.09
$1.39
Analyst Decision
Hold
Strong Buy
Analyst Count
1
2
Target Price
$30.00
$7.00
AVG Volume (30 Days)
53.1K
6.2M
Earning Date
02-04-2026
03-04-2026
Dividend Yield
3.38%
N/A
EPS Growth
7.49
N/A
EPS
4.45
N/A
Revenue
$624,522,000.00
$5,370,000.00
Revenue This Year
$16.30
$35.88
Revenue Next Year
$6.53
N/A
P/E Ratio
$7.99
N/A
Revenue Growth
9.64
14.26
52 Week Low
$25.41
$0.52
52 Week High
$46.00
$1.96

Technical Indicators

Market Signals
Indicator
RM
OCGN
Relative Strength Index (RSI) 41.14 44.80
Support Level $33.23 $1.31
Resistance Level $41.06 $1.70
Average True Range (ATR) 2.01 0.09
MACD -0.19 -0.03
Stochastic Oscillator 21.33 23.08

Price Performance

Historical Comparison
RM
OCGN

About RM Regional Management Corp.

Regional Management Corp is a diversified consumer finance company that provides installment loan products to customers with limited access to consumer credit from banks, thrifts, credit card companies, and other lenders. It is engaged in consumer finance. The company has the core products which are small and large installment loans. The company also offers optional payment and collateral protection insurance. The company's principal source of revenue is interest and fee income on outstanding loans.

About OCGN Ocugen Inc.

Ocugen Inc company focused on discovering, developing, and commercializing novel gene and cell therapies and vaccines that improve health and offer hope for patients across the globe. The company's pipeline includes Modifier Gene Therapy Platform, Novel Biologic Therapy for Retinal Diseases, Regenerative Medicine Cell Therapy Platform, Inhaled Mucosal Vaccine Platform. The company is developing a modifier gene therapy platform designed to fulfill unmet medical needs related to retinal diseases, including inherited retinal diseases ("IRDs"), such as RP, LCA, Stargardt disease, and multifactorial diseases such as dAMD and Geographic Atrophy ("GA").

Share on Social Networks: